Illumina (NASDAQ: ILMN) spun off liquid biopsy company GRAIL a few years ago. But the big genomic sequencing pioneer now...
On March 1, Clover Health (NASDAQ:CLOV) posted losses and mediocre results for the quarter and year ending Dec. 31, 2020....
Okta, Inc. (NASDAQ:OKTA) - Equities researchers at Truist Securiti lowered their FY2023 EPS estimates for shares of Okta in a...
What happened Hydrogen fuel cell stock Plug Power (NASDAQ: PLUG) is down 7.8% as of 12:30 p.m. EDT Wednesday on no obvious news....
Earlier this week, T-Mobile (NASDAQ: TMUS) announced a new partnership with Alphabet's (NASDAQ: GOOG) (NASDAQ: GOOGL) Google, partnering with the search giant on a number of cross-promotions,...
What happened Shares of Coupa Software (NASDAQ: COUP) gained 26.5% in March 2021, according to data from S&P Global Market Intelligence. The maker of...
Did you know that new biotech stocks go public at a rate of about one per week? With so many investment options...
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC...
Team Red might equip all Ryzen 7000 processors with Navi graphics AMD will kit out all of its Zen 4-based Ryzen...
Have you been keeping an eye on the shares of BlackBerry (TSX:BB)(NYSE:BB)? The former smartphone manufacturing giant is under considerable pressure once...
Get breaking news delivered straight into your inbox
Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Rotten Tomato stocks is a wholly-owned subsidiary of Grainne Capital Limited.
While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
© Copyright 2023 RottenTomatoStocks. All Rights Reserved